Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nalbuphine analgesia in polytrauma patients
ChiCTR2300078026Phase 4Not yet recruiting
- Sponsor
- The Third Affiliated Hospital of Southern Medical University
- Start
- Nov 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of nalbuphine and remifentanil in polytrauma (3 arms), sponsored by The Third Affiliated Hospital of Southern Medical University. Primary endpoint: Analgesia scores in each group. Planned start Nov 2023; status: not yet recruiting.
02
Drugs
nalbuphineremifentanil
03
Conditions
polytrauma
Beyond the preview
Go deeper on ChiCTR2300078026.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300078026.